Qrem (Tecnología Regenerativa Qrem, S.L.) is a Barcelona-based medical device company that develops, manufactures and sells Lab-in-a-Box systems for autologous regenerative medicine. Its Qrem Cytokine system pairs an automated device with a sterile single-use kit that produces autologous cytokine-rich serum (SARC) from the patient's own blood in about 36 minutes. Physicians can then apply it in their own practice, without specialised lab infrastructure, to treat musculoskeletal conditions such as knee osteoarthritis and tendinopathies, as well as dermatological and aesthetic indications. The company sells to orthopaedic, rheumatology, sports medicine, pain and aesthetic specialists through a network of partner clinics across Spain, and it received CE marking under the EU Medical Device Regulation (MDR 2017/745) in May 2023. Qrem was founded in Barcelona in 2016 by medical device engineers Josep M. Escuer and Núria Noguera. In 2020 it closed a €1 million capital increase led by Inveready's Inveready Biotech III fund, with business angels co-investing.

Founded
2016
Founders
2
Total funds raised
€1.4M
Rounds
2
Investors
1
Last round
Jan 2023
SectorsMedical Devices, Regenerative Medicine, Orthobiologics, Healthtech Start-up MapHealthtech & Bio › Medical devices & surgical hardware

Suggest a correction

Founders

Josep M. Escuer
Co-founder & CEO
Núria Noguera
Co-founder & R&D Director

Global models 5

Cytori Therapeutics
United States
Sold a point-of-care device plus single-use kits that process a patient's own tissue into regenerative cells for use in the procedure room, the same device-plus-consumable autologous model as Qrem.
~$100M+Comparable
InGeneron
United States · www.ingeneron.com ↗
Sells a point-of-care system with single-use kits that isolates autologous regenerative cells for physicians treating musculoskeletal conditions such as tendon injuries, matching Qrem's model.
~$60MComparable
Nuo Therapeutics
United States · www.nuot.com ↗
Sells the Aurix point-of-care system that turns a patient's own blood into a therapeutic platelet gel at the bedside, a close match to Qrem's autologous blood-derived product.
~$50MComparable
Orthogen
Makes the Orthokine/EOT kits that produce autologous cytokine-rich serum from the patient's blood for knee osteoarthritis and tendon problems, the closest direct match to Qrem's SARC therapy.
n/aComparable
Estar Medical
Sells single-use kits and devices that let physicians prepare autologous platelet-rich plasma in their own practice for orthopaedic and aesthetic use, matching Qrem's in-practice model.
~$10MComparable

In the same niche 72 others

See all in the Start-ups Map →

Notes: Most funded first

Investors 1

Open as list →

Funding rounds 2

·1 not counted
DateRoundAmountLead
Not counted (1)

Not counted in totals

News

No coverage on record yet.
Start typing to search across everything.
↑↓ navigate↵ openesc close? shortcuts
Keyboard shortcuts
/ Ctrl K
Search
j k
Next or previous row
↵
Open the row
Ctrl ↵
Open it in a new tab
[ ]
Previous or next page
?
This list